2014
Corrigendum to 'A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption' [Clin. Immunol. 142 (2012) 252-268]
Publication
Publication
Clinical Immunology , Volume 150 - Issue 1 p. 88- 89
Additional Metadata | |
---|---|
doi.org/10.1016/j.clim.2013.11.001, hdl.handle.net/1765/52421 | |
Clinical Immunology | |
Organisation | Department of Pediatrics |
Allard, S. D., de Keersmaecker, B., de Goede, A., Verschuren, E., Koetsveld, J., Reedijk, M., … Gruters, R. (2014). Corrigendum to 'A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption' [Clin. Immunol. 142 (2012) 252-268]. Clinical Immunology, 150(1), 88–89. doi:10.1016/j.clim.2013.11.001 |